Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found.
https://www.reuters.com/world/maker-wegovy-ozempic-showers-money-us-obesity-doctors-2023-12-01/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.